Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
Merck Sharp & Dohme LLC
AstraZeneca
Verastem, Inc.
Seagen Inc.
Tesaro, Inc.